Skip to main content
. Author manuscript; available in PMC: 2016 Feb 26.
Published in final edited form as: Arthritis Rheum. 2013 Aug;65(8):1985–1994. doi: 10.1002/art.38012

Figure 3.

Figure 3

Percentages of patients achieving a response according to the American College of Rheumatology criteria for 20% improvement (ACR20), 50% improvement (ACR50), and 70% improvement (ACR70) at year 2. Patients received immediate combination therapy (hatched bars), initial methotrexate (MTX) therapy with step-up to combination therapy (shaded bars), or methotrexate (MTX) monotherapy (solid bars) (see Patients and Methods for details). Numbers across the top of the bars are the values represented by the bars themselves. Comparisons across groups for the numbers of patients achieving ACR20, ACR50, and ACR70 improvement were not significant (P = 0.66, 0.23, and 0.51, respectively).